There are more than 80 professions within allied health, and they all share one key responsibility: patient advocacy. Patient ...
Beth Scott, director of case management at the Patient Advocate Foundation, said that their services are more in-demand than ...
Patient advocates can help people navigate billing, services, and a range of other non-medical aspects of living in a nursing home or assisted living. Jeff Somers is a freelancer who has been writing ...
Conner Mertens ’17, a politics major, credits Willamette for igniting his passion for advocacy. Now, he fights for patients with chronic diseases. Conner Mertens ’17, a patient advocate outreach ...
Advocacy groups for patients with neurologic disorders have become a common feature in the landscape of drug and device development and federal research funding allocation. On Capitol Hill, advocates ...
When faced with a loved one’s progressive neurodegenerative disease, like Alzheimer’s, or your child’s rare respiratory disease, you question why researchers and resource-backed pharma cannot bring a ...
Intensivist care and extensivist care — these aren’t medical specialties you’re likely to run into very often, unlike internists, oncologists and dermatologists. But these two types of medical ...
If there’s one habit every doctor wishes you would break, it’s smoking. Quitting significantly improves health and reduces the risk of diseases. And this is true no matter what age you are, from ...
March 9, 2026Biodexa Announces Support for Life’s a Polyp FoundationFirst U.S. Patient Advocacy Group for FAP Patients ...
Every year, pharmaceutical companies spend millions on “patient advocacy.” At its best, this supports families, advances science, and builds genuine partnerships. But too often, those dollars pay for ...
How can CMOs support and partner with their commercialization teams? Everybody’s role within a biotech or pharma company is to get therapy to patients. Along the way, everyone who has a role in ...
Representatives from the National Eczema Association recently met with policymakers on Capitol Hill to discuss stalled step therapy legislation, prior authorization burdens and federal research ...